About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 6573 record(s)
Req # A-2021-000329
The dosage form and route of administration of each drug product that is the subject of a submission for Tacrolimus on the list of Generic Submissions Under Review.Organization: Health Canada
September 2023
Req # A-2021-001604
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, the letters from Health Canada to all applicant companies, including the letter from Health Canada confirming…Organization: Health Canada
September 2023
Req # A-2022-000910
Advise whether the Abbreviated New Drug Submission (ANDS) seeking approval of a generic degarelix acetate product (Control No. 245431) received a Notice of Non-Compliance Withdrawal letter (NON-W).Organization: Health Canada
September 2023
Req # A-2022-001093
The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug subject of the Abbreviated new Drug Submission (ANDS) which was added to Health Canada’s list of “Generic Drug Submissions Under…Organization: Health Canada
September 2023
Req # A-2022-001496
All records surrounding the development, planning, release and advertisement of the Medical Assistance in Dying (MAID) coloring book found here: https://www.virtualhospice.ca/maid/media/3bdlkrve/maid-activity-book.pdf. Limit search period from June…Organization: Health Canada
September 2023
Req # A-2022-001497
All records surrounding the development, planning, release and advertisement of the Medical Assistance in Dying (MAID) coloring book found here: https://www.virtualhospice.ca/maid/media/3bdlkrve/maid-activity-book.pdf. Limit search period from…Organization: Health Canada
September 2023
Req # A-2022-001580
All available documentation relating to the registration of Natural Product Number (NPN) 80115682. Product names are Microsan Encore® Foaming Alcohol Handrub and Microsan® Optidose(TM) Foaming Alcohol Handrub by SC Johnson Professional CA Inc. Any…Organization: Health Canada
September 2023
Req # A-2023-000008
The most recent draft copy of the State of Per and Polyfluoroalkyl Substances (PFAS) Report being prepared by Health Canada.Organization: Health Canada
September 2023
Req # A-2023-000155
The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Manufacturing Practices (GMP) inspection of the…Organization: Health Canada
September 2023
Req # A-2023-000162
The safety summary reports of the hematological monitoring for GEN-Clozapine-associated neutropenia/agranulocytosis. Manufacturer: Mylan. The request references all marketed strengths of GEN-Clozapine tablets (Drug Indentification Numbers (DIN),…Organization: Health Canada
September 2023